In recent years, federal agencies have introduced significant regulatory proposals impacting different facets of the pharmaceutical industry, from drug manufacturing, to reimbursement, to disposal.
Here are 3 major proposals handed down from federal agencies that pharmacists should know:
1. CMS Final Rule on Outpatient Drug Reimbursement
The Centers for Medicare and Medicaid Services (CMS) final rule on reimbursement for outpatient drugs represents a dramatic shift in the way Medicaid programs are reimbursed. Like most regulations, this rule comes with pluses and minuses in terms of how it affects pharmacy. – See more